Compound information
- Natural Products
- ZC2892289
- Molecular Formula
- C22H20N2O4
- Molecular Weight
- 376.14230712 g/mol
- Structure
-
- IUPAC Name
- [4-[methyl(phenyl)carbamoyl]oxyphenyl] N-methyl-N-phenyl-carbamate
- InChI
- InChI=1S/C22H20N2O4/c1-23(17-9-5-3-6-10-17)21(25)27-19-13-15-20(16-14-19)28-22(26)24(2)18-11-7-4-8-12-18/h3-16H,1-2H3
- InChI Key
- AZHVWUCGKBNZAP-UHFFFAOYSA-N
- SMILES
- CN(C(=O)Oc1ccc(OC(=O)N(C)c2ccccc2)cc1)c1ccccc1
- Source
- ZINC000001122259
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 59.08 Å2 | LogP | 3.966 |
LogS | -5.039 | LogD | 3.49 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.434 | Pgp substrate | 0.134 |
HIA | 0.949 | F20 % | 0.83 |
F30 % | 0.287 | Caco-2 | -4.683 |
MDCK | -4.692 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.014 | PPB | 89.802 |
VD | 1.168 | Fu | 1.829 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.109 | CYP1A2 substrate | 0.63 |
CYP2A6 substrate | 0.448 | CYP2B6 substrate | 0.709 |
CYP2C19 inhibitor | 0.942 | CYP2C19 substrate | 0.805 |
CYP2C8 substrate | 0.783 | CYP2C9 inhibitor | 0.9 |
CYP2C9 substrate | 0.352 | CYP2D6 inhibitor | 0.096 |
CYP2D6 substrate | 0.818 | CYP2E1 substrate | 0.536 |
CYP3A4 inhibitor | 0.035 | CYP3A4 substrate | 0.968 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.807 | CL | 4.428 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.859 | Hepatotoxicity | 0.916 |
Mutagenicity | 0.218 | Rat Oral Acute Toxicity | 0.047 |
FDAMDD | 0.473 | Skin Sensitization | 0.999 |
Carcinogenicity | 0.889 | Eye Corrosion | 0.001 |
Eye Irritation | 0.003 | Respiratory Toxicity | 0.681 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 2.311 | IGC50 | 5.49 |
LC50FM | 6.251 | LC50DM | 4.538 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.525 | NR-AR-LBD | 0.23 |
NR-AhR | 0.538 | NR-Aromatase | 0.17 |
NR-ER | 0.939 | NR-ER-LBD | 0.584 |
NR-PPAR-gamma | 0.688 | SR-ARE | 0.855 |
SR-ATAD5 | 0.723 | SR-HSE | 0.508 |
SR-MMP | 0.804 | SR-p53 | 0.753 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.